Jennifer P. Lam - 31 Mar 2022 Form 3 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role: VP of Finance & Administration
Signature: /s/ Jennifer Lam
Issuer symbol: OKUR
Transactions as of: 31 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 05 Apr 2022, 20:02:48 UTC
Next filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RPHM	Common Stock						15,000	31 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RPHM	Stock Option (right to buy)							31 Mar 2022	Common Stock	50,000	$8.66	Direct	F1
holding	RPHM	Stock Option (right to buy)							31 Mar 2022	Common Stock	35,000	$6.69	Direct	F2
holding	RPHM	Stock Option (right to buy)							31 Mar 2022	Common Stock	10,000	$4.58	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the shares vest and become exercisable on September 10, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.
F2	The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.
F3	The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the 2021 Equity Incentive Plan) as of each such vesting date.